What Is a Polyp in the Uterus?

Medically reviewed on 25 August 2026 - Dr. Senai Aksoy
Clinical illustration of the uterine cavity showing an endometrial polyp

Key Takeaways

A uterine polyp is a localised overgrowth of the endometrial lining that is usually benign. Small, silent polyps may simply be monitored, but lesions that cause abnormal bleeding or occupy the uterine cavity can hinder embryo implantation. Management is individualised based on symptoms, size, location, and pregnancy plans.

Key evidence: AAGL practice guidelines for diagnosis and management of endometrial polyps Effect of endometrial polyps on IVF outcomes (Lass et al.) Pregnancy rates after hysteroscopic endometrial polypectomy versus curettage (Nishioka et al., 2023)

Uterine Polyps: What the Finding May Mean — Dr. Senai Aksoy Explains

Uterine Polyps: What the Finding May Mean — Dr. Senai Aksoy Explains

This video was recorded in French. English and Arabic audio dubbing and subtitles are available in the YouTube player settings.

Why uterine polyps sit on the fertility checklist

Most uterine polyps are benign. That fact should come first, because hearing the word “polyp” can cause far more alarm than the finding usually warrants.

Still, a polyp inside the uterus can cause irregular bleeding or occupy part of the cavity where an embryo needs to implant. These growths arise from the endometrium—the delicate mucosal lining of the womb. Some are tiny and discovered by chance during a routine scan. Others cause spotting, heavy periods, or findings that need to be assessed before IVF.

When pathology identifies a non-cancerous growth, the medical report may refer to a “benign endometrial polyp.” In fertility care, the central question is not just the name on the report. What matters is where the polyp sits, whether it disrupts the endometrial cavity, and whether removing it is likely to change the treatment plan.

What is a uterine polyp?

A uterine polyp—also called an endometrial polyp—is a localised overgrowth of endometrial glands and stroma forming a soft, vascular projection into the uterine cavity. It is not a fibroid.

Polyps can be single or multiple. Some attach by a slender stalk (pedunculated), while others have a broad base flush with the uterine wall (sessile). They range in size from a few millimetres to several centimetres across.

FeatureUterine (Endometrial) PolypUterine Fibroid (Leiomyoma)
OriginEndometrial mucosal liningMuscular wall of the uterus (myometrium)
TextureSoft, vascular, pliable tissueDense, firm fibrous-muscular tissue
Relation to CavityGrows directly inside the endometrial cavityOnly submucosal fibroids bulge into the cavity
Primary TreatmentTargeted hysteroscopic polypectomyHysteroscopy, laparoscopy, or observation

This distinction matters in reproductive medicine. The endometrial cavity is where implantation takes place. A benign polyp may become a mechanical obstacle or alter the local environment if it occupies that space.

What causes endometrial polyps?

The precise reason why polyps develop is not always known. They are seen more often with increasing age and with some exposures, such as tamoxifen; they may also be found during infertility evaluation. These associations do not identify a single cause, and having a polyp is not a reflection of lifestyle or personal fault.

Recognised associations and clinical contexts include:

Many women diagnosed with polyps have no recognised association at all. They can also occur in young, healthy women trying to conceive, and their presence is not a reflection of lifestyle or personal fault.

Symptoms: subtle clues versus silent findings

Many uterine polyps are completely silent and produce no symptoms whatsoever. When symptoms do occur, bleeding changes are the most common sign.

Typical symptoms include:

Pelvic pain is uncommon with polyps alone unless they are exceptionally large or prolapsing through the cervix. Because these bleeding symptoms overlap with other conditions—such as ovulatory disorders, adenomyosis, or fibroids—imaging and, when needed, visual assessment help establish the diagnosis.

Why polyps matter for fertility and implantation

Not every polyp prevents pregnancy, but an intracavitary polyp may interfere with embryo implantation.

A polyp can occupy space within the cavity, and biological effects on the local endometrium have also been proposed. These mechanisms help explain why a cavity-distorting lesion may matter, but they do not mean that every polyp prevents implantation.

The American Association of Gynecologic Laparoscopists (AAGL) lists infertility among the clinical settings in which endometrial polyps may be found, while abnormal bleeding remains the most common presentation.

The evidence is not uniform. The older retrospective study by Lass et al. found that small polyps did not lower pregnancy rates, although miscarriage was numerically higher. A later retrospective study by Nishioka et al. (2023) reported higher pregnancy and live-birth rates after hysteroscopic removal than after curettage. These findings can inform discussion of removing a cavity-distorting or symptomatic polyp in selected patients, but they do not prove that every small, asymptomatic polyp must be removed or that removal guarantees a live birth.

To learn more about preparing the lining for transfer, read our guide on endometrial thickness before embryo transfer.

How uterine polyps are diagnosed

Evaluation may involve one or more methods, depending on the symptoms and how clearly the uterine cavity needs to be seen:

  1. Transvaginal ultrasound (TVS): This is often the first test used. A polyp may appear as a focal hyperechoic thickening of the endometrial stripe.
  2. Saline Infusion Sonography (SIS): Sterile saline is gently infused into the uterine cavity during ultrasound. The fluid distends the walls, providing a crisp outline of the polyp’s size, base, and exact attachment site.
  3. Diagnostic Hysteroscopy: This examination provides a direct view of the uterine cavity. A slender camera (hysteroscope) is guided through the cervix into the cavity under fluid distension, allowing the physician to inspect the lining under direct magnification.
  4. Histopathological examination: Removed tissue is evaluated under a microscope to determine its nature and check for hyperplasia or atypical changes.

Diagnostic hysteroscopy provides a direct view of the cavity and can allow treatment during the same procedure when that is appropriate. Whether it is needed depends on the ultrasound findings, symptoms, and clinical plan. For more detail, see our guide on hysteroscopy in female infertility.

When to remove a polyp versus when to observe

Management is never one-size-fits-all. The decision between observation and removal depends on symptoms, size, location, age, menopausal status, and reproductive plans.

Watchful waiting (observation)

May be considered for:

Hysteroscopic polypectomy (removal)

May be considered when:

When removal is chosen, operative hysteroscopy uses direct visual guidance and usually avoids abdominal incisions. AAGL guidance does not favour blind removal when guided removal is available; the appropriate technique and anaesthetic plan depend on the patient and the procedure.

Uterine polyps and IVF: timing the embryo transfer

In IVF and frozen embryo transfer (FET) cycles, assessing and, when appropriate, treating the uterine cavity is an important part of preparation.

When a polyp is diagnosed during ovarian stimulation or before transfer, one possible approach is to complete egg collection and fertilisation, freeze the resulting embryos, and perform hysteroscopic polypectomy in a later cycle. The choice depends on the polyp’s size and location, symptoms, treatment timing, and the overall clinical plan.

A 2026 retrospective cohort study found no difference in live-birth rates between fresh transfer and a freeze-all strategy followed by hysteroscopy. Because this was not a randomised trial, it supports individualised planning rather than a single rule for every patient.

There is no universally required waiting period after polypectomy. Timing is individualised according to healing, symptoms, the extent of the procedure, and the treatment plan.

Evaluating the cavity also involves assessing other factors that influence implantation, such as adenomyosis and IVF or co-existing fibroids and IVF.

Frequently asked questions

Are uterine polyps cancerous?

Most endometrial polyps are benign. The risk of atypical or malignant change is higher with increasing age and postmenopausal bleeding, so tissue that is removed is usually sent for histopathological assessment.

Can a uterine polyp prevent natural pregnancy?

It may, particularly if it occupies the central or fundal cavity or obstructs a tubal opening. However, many women with small polyps conceive without difficulty, so the finding is interpreted in context.

Does every uterine polyp require surgical removal?

No. Small, asymptomatic polyps may regress spontaneously or simply be monitored in selected patients. Removal may be discussed when symptoms, abnormal bleeding, cavity distortion, or fertility plans make treatment relevant.

Is hysteroscopic polyp removal painful?

Hysteroscopic polypectomy may be performed with local anaesthesia, sedation, or another anaesthetic plan depending on the procedure and the patient. Pain and recovery vary; mild cramping and light spotting for a few days are common after the procedure.

Can uterine polyps grow back after removal?

Yes, recurrence is possible. Follow-up is guided by symptoms and the clinician’s assessment; an ultrasound may be appropriate if symptoms return.

What is the difference between a polyp and a fibroid?

A polyp arises from the endometrial mucosal lining and is soft and vascular. A fibroid (myoma) arises from the muscular uterine wall and is dense and firm. Both are usually benign, but they are evaluated and managed differently.

How soon after polyp removal can I attempt pregnancy or an embryo transfer?

There is no single interval that applies to everyone. The timing is individualised according to the extent of removal, healing, symptoms, and the planned treatment.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

For privacy, please send only information needed for an initial reply. Ask the team which secure channel to use for medical reports or identity documents.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.